[Federal Register Volume 63, Number 42 (Wednesday, March 4, 1998)]
[Notices]
[Page 10646]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-5576]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to Section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
National Institute of Allergy and Infectious Diseases Special Emphasis 
Panel (SEP) meeting:

    Name of SEP: Novel HIV Therapies: Integrated Preclinical/
Clinical Program.
    Date: March 30-April 2, 1998.
    Time: 7:30 p.m. to Adjournment.
    Place: Holiday Inn Gaithersburg, Whetstone Conference Room, 2 
Montgomery Village Avenue, Gaithersburg, MD 20879, (301) 948-8900.
    Contact Person: Dr. Allen C. Stoolmiller, Scientific Review 
Adm., 6003 Executive Boulevard, Solar Bldg., Room 4C05, Bethesda, MD 
20892, (301) 496-7966.
    Purpose/Agenda: To evaluate grant applications.
    The meeting will be closed in accordance with the provisions set 
forth in secs. 552b(c)(4) and 552b(c)(6), Title 5, U.S.C. 
Applications and/or proposals and the discussions could reveal 
confidential trade secrets or commercial property such as patentable 
material and personal information concerning individuals associated 
with the applications and/or proposals, the disclosure of which 
would constitute a clearly unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance Programs Nos. 93.855, 
Immunology, Allergic and Immunologic Diseases Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health.)

    Dated: February 24, 1998.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 98-5576 Filed 3-3-98; 8:45 am]
BILLING CODE 4140-01-M